In L-NAME-treated hypertensive rats VSM cells, as well as in DOCA–salt rats, renal hypertensive rats and stroke-prone SHR rats, angiotensin II increased the active form of RhoA, phosphorylation of MYPT1 at T696 and CPI-17 T38. Here, AGT is linked to stroke disorder.